BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 20030684)

  • 1. Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral(®) plus Rapamune(®): four-yr results of a randomized monocenter study.
    Sandrini S; Setti G; Bossini N; Chiappini R; Valerio F; Mazzola G; Maffeis R; Nodari F; Cancarini G
    Clin Transplant; 2010; 24(5):669-77. PubMed ID: 20030684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy.
    Sandrini S; Setti G; Bossini N; Maffei C; Iovinella L; Tognazzi N; Maffeis R; Nodari F; Portolani N; Cancarini G
    Clin Transplant; 2009; 23(1):16-22. PubMed ID: 18727661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment of acute rejections gives favorable long-term function after renal transplantation in small children.
    Qvist E; Their M; Krogerus L; Holmberg C; Jalanko H
    Pediatr Transplant; 2007 Dec; 11(8):895-900. PubMed ID: 17976125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM; Campistol JM; Kreis H; Mourad G; Eris J; Schena FP; Grinyo JM; Nanni G; Andres A; Castaing N; Brault Y; Burke JT
    Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
    Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid.
    Citterio F; Sparacino V; Altieri P; Rigotti P; Calabrese S; Poli M; Vinti V; Segoloni GP
    Transplant Proc; 2005 Mar; 37(2):827-9. PubMed ID: 15848545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early sirolimus therapy in renal transplant recipients at high risk: is it justified?
    Halim MA; Al-Otaibi T; Johny KV; Hamid MH; Al-Waheeb S; Hasaneen H; Awadain WH; Nawas KM; El-Sayed A; Said T; Nair MP; Nampoory MR
    Transplant Proc; 2009 Sep; 41(7):2784-8. PubMed ID: 19765435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
    Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.
    Oberbauer R; Segoloni G; Campistol JM; Kreis H; Mota A; Lawen J; Russ G; Grinyó JM; Stallone G; Hartmann A; Pinto JR; Chapman J; Burke JT; Brault Y; Neylan JF;
    Transpl Int; 2005 Jan; 18(1):22-8. PubMed ID: 15612979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to de novo immunosuppression and steroid elimination.
    Lebranchu Y
    Transplant Proc; 2009; 41(6 Suppl):S39-41. PubMed ID: 19651295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early steroid withdrawal after renal transplantation.
    Colaneri J
    Nephrol Nurs J; 2006; 33(1):89-90. PubMed ID: 16538935
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-center, open, prospective, randomized pilot study comparing cyclosporine versus tacrolimus in simultaneous pancreas-kidney transplantation.
    Boggi U; Vistoli F; Del Chiaro M; Croce C; Morelli L; Coletti L; Signori S; Giannarelli R; Marchetti P; Del Prato S; Rizzo G; Mosca F
    Transplant Proc; 2004 May; 36(4):1064-6. PubMed ID: 15194369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late corticosteroid withdrawal can be safely performed for kidney recipients with stable graft function under pathological confirmation.
    Harada H; Miura M; Ogawa Y; Seki T; Taniguchi A; Takenouchi T; Togashi M; Hirano T
    Clin Transplant; 2006; 20 Suppl 15():26-32. PubMed ID: 16848872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.
    Montagnino G; Sandrini S; Casciani C; Schena FP; Carmellini M; Civati G; Rigotti P; Cossu M; Altieri P; Salvadori M; Federico S; Stefoni S; Cambi V; Albertazzi A; Buoncristiani U; Berloco P; Segoloni G; Boschiero L; Sparacino V; Donati D; Turello E; Dal Canton A; Ponticelli C
    Transplant Proc; 2005 Mar; 37(2):788-90. PubMed ID: 15848532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.